机构:[1]Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, Guangdong, China[2]The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang,524003, Guangdong, China[3]Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou,510000, Guangdong, China[4]Guangdong Provincial Agricultural Reclamation Central Hospital, Zhanjiang,524000, Guangdong, China[5]Department of Respiration, Taishan Hospital Of Traditional Chinese Medicine, Jiangmen, 529200, Guangdong, China
Science and Technology Special Fund of Guangdong Province in 2019 (" Major Projects + Task List “)
(Special Project for Major Science and Technology Innovation Platform and Project Introduction)(No.
2019A201).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|1 区医学
小类|1 区呼吸系统2 区危重病医学
最新[2025]版:
大类|1 区医学
小类|1 区危重病医学1 区呼吸系统
第一作者:
第一作者机构:[1]Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524000, Guangdong, China[2]The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang,524003, Guangdong, China
共同第一作者:
通讯作者:
通讯机构:[2]The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang,524003, Guangdong, China[*1]The Second Affiliated Hospital of Guangdong Medical University, Zhanjiang 524003, Guangdong, China
推荐引用方式(GB/T 7714):
Sun Xishi,Chen Riken,Yao Xiaoyun,et al.circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?[J].American journal of respiratory and critical care medicine.2021,doi:10.1164/rccm.202108-1868LE.
APA:
Sun Xishi,Chen Riken,Yao Xiaoyun,Zheng Zhenzhen,Wang Chaoyu...&Cheng Junfen.(2021).circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?.American journal of respiratory and critical care medicine,,
MLA:
Sun Xishi,et al."circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?".American journal of respiratory and critical care medicine .(2021)